Raphael Pharmaceutical Files Q1 2025 10-Q
Ticker: RAPH · Form: 10-Q · Filed: May 15, 2025 · CIK: 1415397
| Field | Detail |
|---|---|
| Company | Raphael Pharmaceutical Inc. (RAPH) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceutical, quarterly-report
TL;DR
Raphael Pharma (formerly Easy Energy) filed its Q1 2025 10-Q. Based in Israel.
AI Summary
Raphael Pharmaceutical Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Easy Energy Inc., is incorporated in Nevada and operates in the medicinal chemicals and botanical products sector. Its principal executive offices are located in Tel Aviv-Jaffa, Israel.
Why It Matters
This filing provides investors with an update on Raphael Pharmaceutical's financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing basic company information and financial reporting for the period ended March 31, 2025.
Key Numbers
- 000-53002 — Commission file number (Identifies the company's filing with the SEC)
- 26-0204284 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Raphael Pharmaceutical Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- Easy Energy Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Tel Aviv-Jaffa, Israel (location) — Principal executive offices location
FAQ
What is the primary business of Raphael Pharmaceutical Inc.?
Raphael Pharmaceutical Inc. operates in the medicinal chemicals & botanical products sector, as indicated by its Standard Industrial Classification code [2833].
When is the period covered by this 10-Q filing?
This 10-Q filing covers the quarterly period ended March 31, 2025.
What was Raphael Pharmaceutical Inc. previously named?
Raphael Pharmaceutical Inc. was formerly known as Easy Energy Inc., with a date of name change on October 17, 2007.
Where are Raphael Pharmaceutical Inc.'s principal executive offices located?
The principal executive offices of Raphael Pharmaceutical Inc. are located at 4 Lui Paster Street, Tel Aviv-Jaffa, Israel.
In which U.S. state is Raphael Pharmaceutical Inc. incorporated?
Raphael Pharmaceutical Inc. is incorporated in Nevada.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Raphael Pharmaceutical Inc. (RAPH).